IFLR1000

Solvay $5.5 billion acquisition of Cytec

9/12/2015
Acquisition finance, Private acquisition
Select tab

$ 5.5 billion

Completed

9/12/2015

Overview:

  • Belgian chemical company Solvay has completed its $5.5 billion acquisition of US-based Cytec.
  • Solvay secured $6.8 billion in acquisition financing through a combination of debt and equity capital markets offerings.
  • The underwriters for the offerings included Credit Suisse, Morgan Stanley, HSBC and BNP Paribas Fortis.
  • The deal was first announced in July 2015.

Kurt Stumpo - Journalist

Jurisdictions:

United States
Belgium

Deal types:

Acquisition finance
Private acquisition

Practice area:

M&A

Industry sector:

Industrials and manufacturing

Firms:
Clifford Chance

Party: Credit Suisse (Underwriter)

Party: Morgan Stanley (Underwriter)

Party: HSBC (Underwriter)

Party: BNP Paribas Fortis (Underwriter)

Lawyers: Alex Bafi, Cedric Burford, Simon Thomas

Davis Polk & Wardwell

Party: Solvay (Acquirer)

Lawyers: John B Reynolds III, Nick Benham, William Aaronson

Linklaters

Party: Solvay (Acquirer)

Lawyer: Arnaud Coibion

Sullivan & Cromwell

Party: Cytec (Target)

Lawyers: Melissa Sawyer, Stephen Kotran

Related deals